Tuesday, July 25, 2017

The Tasmanian Hep C Buyers’ Club

The New York Times
The Tasmanian Hep C Buyers’ Club

Jefferys, a tall man with a thick silver mustache and beard, knew Gilead Sciences had developed a better option: a highly tolerable 12-week oral treatment with high cure rates, called sofosbuvir and sold under the brand name Sovaldi.

While the drug had been approved in the United States and Europe, it wasn’t yet approved in Australia. And in the United States, the retail price was $1,000 per daily pill — $84,000 in total.
But Jefferys also read that in late 2014, Gilead issued India a voluntary license to allow the manufacture of generic versions of sofosbuvir...

Continue Reading .......

Related On This Blog 
The controversy over expensive new drugs for hepatitis C
Link to research and news articles addressing the high cost of hepatitis C drugs; insurance restrictions - private insurers/Medicaid - and availability of generic versions/India, Egypt and other lower-income countries or through online "buyers clubs"  

No comments:

Post a Comment